Clinical Trial

Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma

Study acronym: CONVERCAP
Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, single-centre, observational study. The analysis of samples of pancreatic tumours and/or metastases taken during biopsy or surgery will lead to the determination of the level of expression of convertases in patients with pancreatic cancer and could be used as an additional prognostic means reinforcing those currently used.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-22; most recent amendment 2026-04-15.
Status change: Not Yet Recruiting → Recruiting 2026-04-15
Trial Details
NCT Number NCT06705335
Lead Sponsor Institut Bergonié
Conditions Pancreas Cancer
Enrollment 50 participants
Start Date 2026-03-27
Primary Completion 2028-01 (estimated)
Study Completion 2029-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-20